Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ISRCTN14626095) titled 'Evaluating very low-level red light therapy for dry age-related macular degeneration' on Sept. 24.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: Parallel
Purpose: Treatment
Primary Sponsor: Low Vision Academy
Condition:
Nonexudative age-related macular degeneration (dry AMD)
Eye Diseases
Intervention:
Patients were randomized (approximate 2:1 allocation ratio) using a computer-generated permuted block sequence (Research Randomizer). Randomisation was performed strictly at the patient level (both eyes of a particip...